U.S. CDC Backs Full Approval of Moderna's COVID-19 Vaccine More Reuters FILE PHOTO: A healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, ...
CDC: Moderna COVID-19 Vaccine Causes Rare Anaphylactic ShockAHC MEDIAHospital Employee Health
Several vaccine makers including Pfizer Inc, Moderna Inc and Novavax Inc are testing versions of their COVID vaccines updated to combat the Omicron variant. Pfizer and Moderna have said their new vaccines also appear to work against the subvariants, even though...
While the public has grown accustomed to calling additional shots "boosters," health officials are nowmoving away from the word "booster,"instead calling this year's shots the "2023-2024 COVID-19 vaccine" or simply the"updated COVID-19 vaccine."This clarification helps distinguish previous addit...
LOS ANGELES, June 24 (Xinhua) -- Vaccine advisers to the U.S. Centers for Disease Control and Prevention (CDC) voted on Thursday to support recommending the Moderna COVID-19 vaccine for use in people ages 6 through 17 years old.
Investing.com — 周三早盘,疫苗制造商Moderna和诺瓦瓦克斯医药的股价略有下跌,Moderna下跌1%,诺瓦瓦克斯医药下跌1.3%。 这是在美国疾病控制与预防中心(CDC)的外部专家小组于周二提出更改疫苗接种建议之后发生的。 该小组建议,更新的COVID-19疫苗应仅提供给那些面临严重疾病风险的人群。
美国疾病管制暨预防中心(CDC)今天发布的一份新研究显示,莫德纳(Moderna)COVID-19疫苗在防止住院上,保护力较辉瑞(Pfizer)BNT疫苗持久。 CDC研究人员分析今年3月11日到8月15日近3689名感染COVID-19症状严重的住院成人,这段时间含括后来导致疫情复燃的Delta变异株(最先出现于印度)的流行期。
Like with Pfizer's COVID-19 vaccine, adults at "high risk" who were first vaccinated with Moderna's doses at least six months ago can also receive a third shot of any of the vaccines, the committee said. That includes seniors 65 and older, as well as those vulnerable to severe COVID...
昨天,CDC发言人首次透露,入境美国,必须完全注射已获FDA授权或者被世卫列为紧急用途的6种疫苗,包括:辉瑞、阿斯利康、强生、Moderna、中国国药和北京科兴。 白宫表示:飞往美国的外国公民,在登机前出示3天内核酸阴性检测报告和全面接种疫苗证明,就可以入境美国。
The FDA and CDC previously signed off on booster shots of the COVID-19 vaccine from Pfizer Inc and partner BioNTech SE for the same groups included in the Moderna recommendations. Pfizer released data on Thursday suggesting that a booster dose was highly protecti...